首页 › 基金 › Venrock Adviser, LLC › KRRO

Venrock Adviser, LLC 对 KRRO 的持仓历史

KORRO BIO INC · 医疗保健

Venrock Adviser, LLC 在 Q3 2026 的 13F 申报中披露持有 KRRO(KORRO BIO INC)443,431 股,市值约 US$4.4M,约占其申报组合的 0.21%,在其申报持仓中市值排名第 31 位。 Venrock Adviser, LLC 最近 3 个申报季度中有 3 个季度披露了 KRRO 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)443.43K 股
申报持仓市值$4.39M
组合权重0.21%
首次申报Q1 2026
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Venrock Adviser, LLC 对 KRRO 的持仓演变

Venrock Adviser, LLC 于 Q1 2026 首次披露 KRRO 持仓:1,009,500 股(约 US$11.4M)。 该持仓在 Q2 2026 达到峰值 1,009,500 股,市值约 US$13.3M。 在 3 次申报中,Venrock Adviser, LLC 0 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 443,431 股、市值约 US$4.4M,环比减持 -566,069 股。。 持仓曾出现大幅变动:Q3 2026 减持约 56% (随后一个季度股价上涨 28%)。

逐季持仓明细

季度股数金额变化
Q1 2026 1.01M $11.43M 新进
Q2 2026 1.01M $13.31M 持有
Q3 2026 443.43K $4.39M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 KRRO 与 13F 数据

KRRO(KORRO BIO INC)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 KRRO,申报仓位最大的包括:Lynx1 Capital Management LP (US$15.3M), NEA Management Company, LLC (US$12.9M), Atlas Venture Life Science Advisors, LLC (US$7.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 KRRO 的基金

查看 KRRO 的全部基金持有人 →

常见问题

How long has Venrock Adviser, LLC held KRRO?

Venrock Adviser, LLC has disclosed KRRO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Venrock Adviser, LLC's current position in KRRO?

As of Q3 2026, Venrock Adviser, LLC holds 443.43K shares of KRRO (KORRO BIO INC), valued at $4.39M, representing 0.21% of its reported portfolio and ranking #31.

Has Venrock Adviser, LLC been buying or selling KRRO?

In the latest 13F filing (Q3 2026), Venrock Adviser, LLC reduced its position in KRRO. The position peaked in Q2 2026 at 1.01M shares.

Which other funds hold KRRO?

Other major institutional holders of KRRO include Lynx1 Capital Management LP, NEA Management Company, LLC, Atlas Venture Life Science Advisors, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.